Free p-cresol is associated with cardiovascular disease in hemodialysis patients
- PMID: 18305466
- DOI: 10.1038/ki.2008.31
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
Abstract
Cardiovascular disease (CVD) is highly prevalent in chronic kidney disease, suggesting that molecules retained in uremia might contribute to this increased risk. We explored the relationship between p-cresol, a protein-bound uremic retention solute, and CVD by comparing the strength of this relationship relative to traditional and novel cardiovascular risk factors. Univariate Cox proportional hazard analysis showed that the free serum p-cresol concentration was significantly associated with CVD when the primary end point was the time to the first cardiovascular event. In multivariate analysis, free p-cresol was significantly associated with CVD in non-diabetics. In diabetic patients, however, a significant relationship between p-cresol and cardiovascular events could not be demonstrated despite their having significantly higher p-cresol levels. Our study shows that free p-cresol is a novel cardiovascular risk factor in non-diabetic hemodialysis patients.
Similar articles
-
p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.Clin J Am Soc Nephrol. 2010 Jul;5(7):1182-9. doi: 10.2215/CJN.07971109. Epub 2010 Apr 29. Clin J Am Soc Nephrol. 2010. PMID: 20430946 Free PMC article.
-
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.Kidney Int. 2006 Mar;69(6):1081-7. doi: 10.1038/sj.ki.5000115. Kidney Int. 2006. PMID: 16421516
-
The uremic retention solute p-cresyl sulfate and markers of endothelial damage.Am J Kidney Dis. 2009 Nov;54(5):891-901. doi: 10.1053/j.ajkd.2009.04.022. Epub 2009 Jul 17. Am J Kidney Dis. 2009. PMID: 19615803
-
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21. Kidney Int. 2017. PMID: 28739139 Free PMC article. Clinical Trial.
-
Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators.PLoS One. 2015 May 4;10(5):e0126048. doi: 10.1371/journal.pone.0126048. eCollection 2015. PLoS One. 2015. PMID: 25938230 Free PMC article.
Cited by
-
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. doi: 10.1681/ASN.2015121302. Epub 2016 May 26. J Am Soc Nephrol. 2016. PMID: 27230658 Free PMC article.
-
Significance of the Gut Microbiota in Acute Kidney Injury.Toxins (Basel). 2021 May 22;13(6):369. doi: 10.3390/toxins13060369. Toxins (Basel). 2021. PMID: 34067285 Free PMC article. Review.
-
A fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis.Int J Nephrol Renovasc Dis. 2015 Mar 13;8:25-8. doi: 10.2147/IJNRD.S75960. eCollection 2015. Int J Nephrol Renovasc Dis. 2015. PMID: 25792850 Free PMC article. Review.
-
Advances in Stroke Prevention.J Transl Int Med. 2018 Oct 9;6(3):105-114. doi: 10.2478/jtim-2018-0024. eCollection 2018 Sep. J Transl Int Med. 2018. PMID: 30425946 Free PMC article.
-
p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.Clin J Am Soc Nephrol. 2010 Jul;5(7):1182-9. doi: 10.2215/CJN.07971109. Epub 2010 Apr 29. Clin J Am Soc Nephrol. 2010. PMID: 20430946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical